How can pharmaceutical companies get to insights-driven customer engagement, that is the subject of today's program. We meet with one of our favorite marketing leaders over in Silicon Valley, Leilani Latimer who leads Global Marketing as Sr. Di
In our CEO series, we meet with Janssen's Group Chairman to review blood cancer awareness month, discuss how where we are in the cure for cancer and look at how big pharma should help patients manage the disease journey. Ulrich Neumann, US Mana
While the market becomes increasingly crowded with innovator drugs, pharma is finding it harder to recoup development costs. Join our panel of experts to understand how we should build innovative, cost-effective payment models based on 21st-ce
It's become widely understood that a focus on patient value has become mission critical as we witness the force of consumerization in healthcare. Join us for a wide ranging conversation on the new digital ecosystem and the type of engagement m
Join us for this critical discussion about exploding cost in cancer care. Ahead of ASCO, we'll address some of the value frameworks and metrics, and what pharma ought to do to provide better evidence for their prices. You'll get to hear a prett
In this conversation with pharma change maker Paulo Moreira, we'll discuss how clinical trials and drug development can become more patient friendly. Paulo is EMD Serono's Vice President and Head of Global Clinical Operations for External Innov
In this conversation with renowned industry expert Maria Whitman of ZS Associates we'll discuss the overarching trends in Oncology that are most important to consider in terms of value and market access, explore the role of pathways and new mod